This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.




2b0s

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px<br /> <applet load="2b0s" size="450" color="white" frame="true" align="right" spinBox="true" caption="2b0s, resolution 2.30&Aring;" /> '''Crystal structure a...)
Next diff →

Revision as of 12:36, 8 November 2007


2b0s, resolution 2.30Å

Drag the structure with the mouse to rotate

Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with MN peptide

Overview

Human monoclonal antibody 2219 is a neutralizing antibody isolated from a, human immunodeficiency virus type 1-infected individual. 2219 was, originally selected for binding to a V3 fusion protein and can neutralize, primary isolates from subtypes B, A, and F. Thus, 2219 represents a, cross-reactive, human anti-V3 antibody. Fab 2219 binds to one face of the, variable V3 beta-hairpin, primarily contacting conserved residues on the, N-terminal beta-strand of V3, leaving the V3 crown or tip largely, accessible. Three V3/2219 complexes reveal the antibody-bound, conformations for both the N- and C-terminal regions that flank the V3, crown and illustrate how twisting of the V3 loop alters the relative, dispositions and pairing of the amino acids in the adjacent V3, beta-strands and how the antibody can accommodate V3 loops with different, sequences.

About this Structure

2B0S is a Single protein structure of sequence from Homo sapiens with EDO and ACY as ligands. Full crystallographic information is available from OCA.

Reference

Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity., Stanfield RL, Gorny MK, Zolla-Pazner S, Wilson IA, J Virol. 2006 Jun;80(12):6093-105. PMID:16731948

Page seeded by OCA on Thu Nov 8 14:42:33 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools